U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07668232) titled 'Efficacy and Safety of Mirabegron Versus Oxybutynin After Posterior Urethral Valve Ablation' on June 07.
Brief Summary: Posterior urethral valve is the main cause of bladder outlet obstruction in male infants and the most common cause of obstructive uropathy leading to chronic renal failure and end-stage renal disease in children.The incidence of posterior urethral valve is approximately 1:7,000-8,000 live births.
Study Start Date: Jan. 01, 2025
Study Type: INTERVENTIONAL
Condition:
Posterior Urethral Valve
Intervention:
DRUG: Mirabegron
To assess the efficacy and the safety of Mirabegron and Oxybutynin drugs after posterior ...